Company profile

Health Union

Patient Engagement & SupportAcquired stage

Company profile

About Health Union

Health Union operates condition-specific online communities and uses AI to connect patients with relevant health information, peer support, and clinical trial opportunities.

Company description Health Union official website

Primary marketPatient Engagement & Support
Commercial modelCommercial information available on request
Company presenceLinkedIn
Work at Health Union?

Claim this profile to manage Company information and connect with the Health AI Central audience.

Claim this listing

01 · Operating footprint

Where the Company operates

Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.

Clinical focus

  • Cancer
  • complex and rare conditions across 125+ communities
  • Idiopathic Hypersomnia
  • Primary Biliary Cholangitis

Who it serves

  • Healthcare Brands
  • Medical Device Companies
  • Pharma
  • Research Teams

Deployment & integration

Cloud Saas deployment with recorded integration context.

Geographic context

MarketsUnited States
Company sourceOfficial website

Company milestones

Platform expansion

Launched 2027 Innovation Suite with AI personalization tools (June 2026), expanded portfolio with new communities in Oncology and Rare Diseases (February 2026), launched Social Health Awards (2026), partnership with Institute for Responsible Influence for patient advocacy standards (April 2026)

Partnerships

Recorded partners

  • 95% of Top 20 Pharma Manufacturers
  • Institute for Responsible Influence
  • solli (2026 Pharma Marketing Pulse Report partner)

02 · Flagship portfolio

Products, workflows, and platform capabilities

Selected source-backed Company products and the available commercial context.

2027 Innovation Suite

AI-powered personalization tools combining community leadership with advanced AI for patient-HCP connections

Platform · Cloud SaaSCompany source

360° Community Connect

Coordinated brand advertising across patient and HCP communities using shared behavioral signals

Platform · Cloud SaaSCompany source

Clinical Solutions

Patient-centric approach throughout clinical trial design, recruitment, and patient experience

Service · Cloud SaaSCompany source

Community-Based Activation and Data Platform

Industry's first and largest community-based activation and data platform for health engagement

Platform · Cloud SaaSCompany source

DTC Advertising Solutions

Reach highly engaged patients through influencers, audience activations, and content sponsorships

Platform · Cloud SaaSCompany source

HCP Advertising & Solutions

Access the largest first-party HCP data set for omnichannel programmatic activation

Platform · Cloud SaaSCompany source

Insights & Research Solutions

Tech-enabled research tools delivering qualitative and quantitative health journey intelligence

Platform · Cloud SaaSCompany source

03 · Research intelligence

Research Intelligence evidence

Publications, preprints, clinical validation, and regulatory records in Evidence Position order.

Evidence position

Publications, clinical validation, and regulatory records connected to this Company appear here.

Research

Publications & preprints

Quality of Life Endpoints in Advanced Gastrointestinal Cancer Trials: Systematic Review of Inclusion, Challenges, and Implications (2020-2024).

Clinical oncology (Royal College of Radiologists (Great Britain)) · Sep 1, 2026

Clinical Manifestations, Diagnosis, and Therapeutic Advances in May-Thurner Syndrome: A Comprehensive Literature Review.

Current problems in cardiology · Jul 19, 2026

Heated nebulization of ambroxol hydrochloride: engineering submicron aerosols for pulmonary drug delivery.

International journal of pharmaceutics · Jun 20, 2026

Hydrocortisone Dosing Frequency in Intensive Care Unit Patients With Septic Shock: A Comparison of 2 Regimens.

The Annals of pharmacotherapy · Mar 1, 2026

Potential Benefit of Inferior Turbinate Reduction With Adenotonsillectomy for Obstructive Sleep Apnea.

JAMA otolaryngology-- head & neck surgery · Nov 1, 2025

Graft remodelling of hamstring ACL graft and secondary meniscal lesions are affected by tibial slope and body mass index.

Journal of experimental orthopaedics · Oct 1, 2025

Clinical validation

Clinical-trial records

Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer

NCT05624996 · Mentioned · RECRUITING

Two Studies for Patients With High Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a High Gene Risk Score, The PREDICT-RT Trial

NCT04513717 · Mentioned · ACTIVE NOT RECRUITING

Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease

NCT05174169 · Mentioned · RECRUITING

ETIC (Therapeutic Education in Heart Failure)

NCT01065142 · Sponsor · ACTIVE NOT RECRUITING

Clinical Study on ShouTai Pills for Improving Reduced Ovarian Reserve

NCT07737847 · Sponsor · NOT YET RECRUITING

Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer

NCT01810913 · Mentioned · RECRUITING

Regulatory

Regulatory records

No linked records are currently available.

04 · Company-reported outcomes

Outcomes and case studies

Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.

50M+ consented patients/caregivers

First-party data platform

9.5M healthcare professionals reached

HCP community engagement

8.3M+ HCP records representing 2.8M NPIs

Largest unique first-party HCP dataset

178M+ annual reach

Community and programmatic activation

100K+ patient leaders and influencers

Contributing community members

40K+ pieces of original content

Patient-authored articles

Top 20 Pharma Manufacturers

Engaging patients and HCPs through community-based activation and data platform

95% of the Top 20 Pharma Manufacturers are Partners

05 · Leadership

Leadership team

Leadership profiles and professional links from the current Company record.

Erin Poyant

Erin Poyant

Content Writer | Health Leader

LinkedIn
Jenny J.

Jenny J.

Rare Disease Patient Leader Influencer

LinkedIn
Porscha Simmons

Porscha Simmons

Writer/Health Advocate

LinkedIn

Joey Fontana

Vice President, Business Development

LinkedIn

Katie MacTurk

Vice President, Insights

LinkedIn

Courtney Nolan Robertson

Vice President, Insights

LinkedIn

06 · Company updates

Updates from Health Union

Recent articles published on Health Union's official website.

07 · HAIC coverage

Coverage and analysis

Health AI Central reporting that mentions this Company.

No HAIC coverage is currently linked to this Company.

08 · Official presence

Company sources and channels

Curated official destinations from the active Company record.

09 · Market pathway

Additional Companies in this Market

Other active Companies in the same market, selected alphabetically from the HAIC directory.

Market context

Patient Engagement & Support

Companies using AI to engage patients, provide health education, facilitate peer support, offer AI health coaching, or help patients navigate their healthcare journey. Includes patient communities, AI health mentors, peer support networks, and platforms that empower patients to take an active role in managing their own health.

Explore the full market directory or compare this Company with additional active profiles.

View all Companies in this market

10 · Pro research

Coming soon

Expanded Company research is in development.

Health AI Central Pro · Coming Soon

Deeper Company research is coming soon.

Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.

ResearchEvidence analysis

Linked research, clinical, and regulatory source pathways.

CompanyTechnical context

Expanded product, deployment, integration, and partnership research.

MethodSource & review record

Record-level provenance and review context.

Coming Soon